Nyxoah SA (NYXH)
8.00
-0.28
(-3.38%)
USD |
NASDAQ |
Nov 22, 16:00
7.99
-0.01
(-0.12%)
After-Hours: 20:00
Nyxoah Shareholders Equity (Quarterly): 116.95M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 116.95M |
| June 30, 2024 | 128.78M |
| March 31, 2024 | 94.16M |
| December 31, 2023 | 108.35M |
| September 30, 2023 | 114.89M |
| June 30, 2023 | 125.60M |
| March 31, 2023 | 136.33M |
| December 31, 2022 | 129.04M |
| Date | Value |
|---|---|
| September 30, 2022 | 130.79M |
| June 30, 2022 | 144.41M |
| March 31, 2022 | 159.17M |
| December 31, 2021 | 168.27M |
| June 30, 2021 | 101.31M |
| March 31, 2021 | 107.27M |
| June 30, 2020 | 28.58M |
| December 31, 2019 | 2.645M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.645M
Minimum
Dec 2019
168.27M
Maximum
Dec 2021
112.29M
Average
121.27M
Median
Shareholders Equity (Quarterly) Benchmarks
| Galapagos NV | 3.197B |
| UCB SA | 9.597B |
| Mithra Pharmaceuticals SA | -9.487M |
| Celyad Oncology SA | 1.107M |
| MDxHealth SA | 16.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 159.45M |
| Total Liabilities (Quarterly) | 42.51M |
| Debt to Equity Ratio | 0.1866 |
| Current Ratio | 5.283 |
| Net Debt Paydown Yield | -0.73% |